Shoeshine
|
Friday 14th November 2003 |
Text too small? |
The issues are old ones. First, the company didn't live up to the 2001 information memorandum ebitda (earnings before interest, tax, depreciation and amortisation) forecast of $18.3 million for the August 2002 year.
That's disappointing for everyone but in the context of a rocketing exchange rate, low beef prices for Tru-Test's customers and the Australian drought, it's scarcely surprising.
The Neuronz purchase has also aggravated some shareholders but, like the company's financial performance, that was known before last year's annual meeting, at which, apparently, no questions were asked.
The theory getting most traction is that someone is trying to unsettle shareholders and turn up the gas on Tru-Test's board and management to smooth the path of a takeover.
The natural candidate for the bidder is Skellmax Industries, whose largest shareholder, Axa Asia Pacific, has 5.67%.
It's a small country. Axa is also one of Tru-Test's shareholders.
No comments yet
IPL - Interim Results HY27
SEK - Seeka Announces Launch of 2026 Grower Loyalty Share Scheme
SAN - Sanford delivers a record profit for FY26
November 17th Morning Report
MPG - Metro Performance Glass Limited- Receipt of Takeover Notice
SKO - Serko FY27 Half Year Results Announcement
TRU - TruScreen Receives Product Registration in Kenya
TEM - Transaction in Own Shares
AIA - October 2026 Monthly traffic update
PFI - Q1 FY27 Dividend and Leasing Update